[go: up one dir, main page]

WO2011126264A3 - Method for increasing activity in human stem cell - Google Patents

Method for increasing activity in human stem cell Download PDF

Info

Publication number
WO2011126264A3
WO2011126264A3 PCT/KR2011/002358 KR2011002358W WO2011126264A3 WO 2011126264 A3 WO2011126264 A3 WO 2011126264A3 KR 2011002358 W KR2011002358 W KR 2011002358W WO 2011126264 A3 WO2011126264 A3 WO 2011126264A3
Authority
WO
WIPO (PCT)
Prior art keywords
stem cell
mesenchymal stem
human stem
increasing activity
cell aggregate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2011/002358
Other languages
French (fr)
Korean (ko)
Other versions
WO2011126264A2 (en
Inventor
김효수
강현재
이은주
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seoul National University Hospital
Original Assignee
Seoul National University Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020100053183A external-priority patent/KR20110112164A/en
Application filed by Seoul National University Hospital filed Critical Seoul National University Hospital
Priority to EP11766115A priority Critical patent/EP2557154A2/en
Priority to AU2011239119A priority patent/AU2011239119A1/en
Priority to CN2011800180070A priority patent/CN102822331A/en
Priority to BR112012025285A priority patent/BR112012025285A2/en
Priority to US13/639,169 priority patent/US20130028873A1/en
Publication of WO2011126264A2 publication Critical patent/WO2011126264A2/en
Publication of WO2011126264A3 publication Critical patent/WO2011126264A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0665—Blood-borne mesenchymal stem cells, e.g. from umbilical cord blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2525/00—Culture process characterised by gravity, e.g. microgravity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Provided are a method for preparing a highly active human mesenchymal stem cell, which includes forming a spherical cell aggregate by cultivating human mesenchymal stem cells against gravity; a highly active stem cell aggregate prepared thereby; a cell theraputic including the stem cell aggregate; and a method for forming a spherical cell aggregate by cultivating human mesenchymal stem cells, wherein the amount of E-cadherin in the mesenchymal stem cell is increased during the cultivation.
PCT/KR2011/002358 2010-04-05 2011-04-05 Method for increasing activity in human stem cell Ceased WO2011126264A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP11766115A EP2557154A2 (en) 2010-04-05 2011-04-05 Method for increasing activity in human stem cell
AU2011239119A AU2011239119A1 (en) 2010-04-05 2011-04-05 Method for increasing activity in human stem cell
CN2011800180070A CN102822331A (en) 2010-04-05 2011-04-05 Method for increasing activity in human stem cell
BR112012025285A BR112012025285A2 (en) 2010-04-05 2011-04-05 method to increase activity in human stem cells
US13/639,169 US20130028873A1 (en) 2010-04-05 2011-04-05 Method for increasing activity in human stem cell

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2010-0031061 2010-04-05
KR20100031061 2010-04-05
KR10-2010-0053183 2010-06-07
KR1020100053183A KR20110112164A (en) 2010-04-05 2010-06-07 How to increase the activity of human stem cells

Publications (2)

Publication Number Publication Date
WO2011126264A2 WO2011126264A2 (en) 2011-10-13
WO2011126264A3 true WO2011126264A3 (en) 2012-03-08

Family

ID=44763387

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/002358 Ceased WO2011126264A2 (en) 2010-04-05 2011-04-05 Method for increasing activity in human stem cell

Country Status (1)

Country Link
WO (1) WO2011126264A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof
CN106148266A (en) * 2015-04-20 2016-11-23 烟台赛泽生物技术有限公司 A kind of immunocyte culture medium and the additive of this culture medium
TWI724528B (en) * 2019-09-04 2021-04-11 三顧股份有限公司 Three-dimensional cell spheroid with high proliferation activity, and the producing method and use therefor
CN113577394B (en) * 2021-07-08 2022-09-09 中国人民解放军西藏军区总医院 Method for preparing biological gel-cell polymer system by umbilical cord mesenchymal stem cells and application of umbilical cord mesenchymal stem cells in low oxygen condition

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100012153A (en) * 2008-07-28 2010-02-08 서울대학교병원 Method for separating high activity stem cells form human stem cells and high activity stem cells separated by the method

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100012153A (en) * 2008-07-28 2010-02-08 서울대학교병원 Method for separating high activity stem cells form human stem cells and high activity stem cells separated by the method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BARTOSH, T.J. ET AL.: "Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties", PROC. NATL. ACAD. SCI. USA, vol. 107, no. 31, 19 July 2010 (2010-07-19), pages 13724 - 13729, XP055232564, DOI: doi:10.1073/pnas.1008117107 *
FRITH, J.E. ET AL.: "Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential", TISSUE ENGINEERING: PART C, vol. 16, no. 4, 9 November 2009 (2009-11-09), pages 735 - 746 *
WELTER, J.F. ET AL.: "Simplification of aggregate culture of human mesenchymal stem cells as a chondrogenic screening assay", BIOTECHNIQUES, vol. 42, no. 6, June 2007 (2007-06-01), pages 732, 734 - 737, XP008097909, DOI: doi:10.2144/000112451 *
ZHU, H. ET AL.: "A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone", NATURE PROTOCOLS, vol. 5, no. 3, 25 February 2010 (2010-02-25), pages 550 - 560, XP009172805, DOI: doi:10.1038/nprot.2009.238 *

Also Published As

Publication number Publication date
WO2011126264A2 (en) 2011-10-13

Similar Documents

Publication Publication Date Title
HUE036910T2 (en) A method of producing a base medium for cell-based tissue cell stem cells, cell-mediated binding to stem cells, and its cultivation and differentiation using a cell therapy agent.
WO2011011302A3 (en) Differentiation of human embryonic stem cells
WO2010120785A3 (en) Methods and compositions for stem cell cultures
WO2009012428A3 (en) Differentiation of human embryonic stem cells
WO2012149468A3 (en) Instruments and methods for the implantation of cell-seeded substrates
EP2633577A4 (en) Negative active material, method for preparing the same and lithium ion battery comprising the same
WO2012074818A3 (en) Compositions and methods for 3-hydroxypropionic acid production
WO2012056110A3 (en) Cell culture material based on microbial cellulose
WO2012103261A3 (en) Compositions and methods for succinate production
WO2007115336A3 (en) A shape-based approach for scaffoldless tissue engineering
MX2014014337A (en) High-concentration stem cell production method.
WO2012098537A8 (en) Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
IL214486A (en) Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissue assemblies
MX2013007650A (en) Animal cell culturing method.
AU2012248333A2 (en) Pluripotent stem cell-derived brown adipocytes, pluripotent stem cell-derived cell aggregate, method for producing same, and cell therapy and medical therapy therefor
WO2009073523A3 (en) De-differentiation of human cells
WO2010135639A3 (en) Compositions and methods for promoting beta cell maturity
WO2012126013A3 (en) Method for making pluripotent stem cells
WO2011112601A3 (en) Continuous flow bioreactor for magnetically stabilized three-dimensional tissue culture
CA2927062C (en) Muscle cell patches and uses therefor
CA2866697A1 (en) Reprogramming of aged adult stem cells
WO2011126264A3 (en) Method for increasing activity in human stem cell
WO2011142832A3 (en) Stem cells derived under low oxygen conditions
WO2011102680A3 (en) Cd49f promoting proliferation, multipotency and reprogramming of adult stem cells through pi3k/akt/gsk3 pathway
HK1259180A1 (en) Method for increasing osteoblastic function

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201180018007.0

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11766115

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13639169

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2011766115

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2011239119

Country of ref document: AU

Date of ref document: 20110405

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112012025285

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 112012025285

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20121003